BILBERRY 25% PLUS Trademark
Trademark Overview
On Tuesday, September 17, 2002, a trademark application was filed for BILBERRY 25% PLUS with the United States Patent and Trademark Office. The USPTO has given the BILBERRY 25% PLUS trademark a serial number of 78165001. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, September 29, 2003. The BILBERRY 25% PLUS trademark is filed in the Pharmaceutical Products category with the following description:
Food Supplements
General Information
| Serial Number | 78165001 |
| Word Mark | BILBERRY 25% PLUS |
| Filing Date | Tuesday, September 17, 2002 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Monday, September 29, 2003 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Food Supplements |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 25, 2002 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | NOT AVAILABLE |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 01 - Individual |
| Address | Westwood, NJ 07675 |
Trademark Events
| Event Date | Event Description |
| Monday, September 29, 2003 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, February 12, 2003 | NON-FINAL ACTION E-MAILED |
| Wednesday, February 5, 2003 | ASSIGNED TO EXAMINER |
